Search hospitals > California > Sacramento
Sutter Medical Center Sacramento
Claim this profileSacramento, California 95816
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Recurrence
Conducts research for Adenocarcinoma
Conducts research for Breast Cancer
269 reported clinical trials
16 medical researchers
Summary
Sutter Medical Center Sacramento is a medical facility located in Sacramento, California. This center is recognized for care of Cancer, Lung Cancer, Recurrence, Adenocarcinoma, Breast Cancer and other specialties. Sutter Medical Center Sacramento is involved with conducting 269 clinical trials across 540 conditions. There are 16 research doctors associated with this hospital, such as Ari Baron, MD, Christopher Jones, Deepti Behl, and Yung S. Yim.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage III
Top PIs
Ari Baron, MDAlta Bates Summit Medical Center-Herrick Campus7 years of reported clinical research
Expert in Cancer
Studies Lung Cancer
28 reported clinical trials
66 drugs studied
Christopher JonesSutter Medical Center Sacramento3 years of reported clinical research
Studies Cancer
Studies Prostate Cancer
23 reported clinical trials
62 drugs studied
Deepti BehlCalifornia Pacific Medical Center-Pacific Campus4 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
49 drugs studied
Yung S. YimSutter Medical Center Sacramento4 years of reported clinical research
Studies Leukemia
Studies Cancer
14 reported clinical trials
43 drugs studied
Clinical Trials running at Sutter Medical Center Sacramento
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Melanoma
Squamous Cell Carcinoma
Pancreatic Cancer
Ovarian Tumors
Meningioma
Prostate Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Sutter Medical Center Sacramento?
Sutter Medical Center Sacramento is a medical facility located in Sacramento, California. This center is recognized for care of Cancer, Lung Cancer, Recurrence, Adenocarcinoma, Breast Cancer and other specialties. Sutter Medical Center Sacramento is involved with conducting 269 clinical trials across 540 conditions. There are 16 research doctors associated with this hospital, such as Ari Baron, MD, Christopher Jones, Deepti Behl, and Yung S. Yim.